Our website uses cookies to distinguish you from other users of our website to provide you with the most relevant experience by remembering your preferences and repeat visits. By clicking on ‘Accept’ you consent to our cookie policy. However, you may visit ‘Cookie Settings’ to provide a controlled consent.

Accept

Sector Category: Life Sciences

NSV News Portfolio News
Akarna Therapeutics
October 17, 2017

Akarna Therapeutics

Acquired by Allergan. Focused on the development of a small molecule therapy for the treatment of NASH.

Read More
Trellis Bioscience
October 17, 2017

Trellis Bioscience

Developer of CellSpot platform to derive therapeutic antibodies directly from the human immune system.

Read More
Therox
October 17, 2017

Therox

Acquired by Zoll Medical. Developer of SuperSaturated Oxygen (SSO2) therapy to complement percutaneous coronary intervention.

Read More
Resolve Therapeutics
October 17, 2017

Resolve Therapeutics

Focused on the development of a biologic therapy for Lupus and Sjögren’s Syndrome.

Read More
Ovizio Imaging Systems
October 17, 2017

Ovizio Imaging Systems

Provider of digital holographic microscopy technology.

Read More
biomodal
October 17, 2017

biomodal

Focused on the development of tools for epigenetic analysis.

Read More
Novadip
September 28, 2017

Novadip

Focused on the development of therapies for hard and soft tissue reconstruction from autologous adipose stem cells.

Read More
Paradigm Diagnostics
September 28, 2017

Paradigm Diagnostics

Acquired by Exact Sciences. Provider of a molecular diagnostic test to guide clinical decision making for cancer patients.

Read More
iCAD
September 27, 2017

iCAD

Provider of cancer detection and radiation therapy solutions.

Read More
Cookie Policy Website powered by 100% renewable energy Privacy Policy